Fish Consumption, Omega-3 Fatty Acids, and Risk of Cardiovascular Disease
Overview
Affiliations
Introduction: Data on omega-3 polyunsaturated fatty acids in relation to cardiovascular disease are limited in women. The aim of this study was to examine longitudinal relations of tuna and dark fish, α-linolenic acid, and marine omega-3 fatty acid intake with incident major cardiovascular disease in women.
Methods: This was a prospective cohort study of U.S. women participating in the Women's Health Study from 1993 to 2014, during which the data were collected and analyzed. A total of 39,876 women who were aged ≥45 years and free of cardiovascular disease at baseline provided dietary data on food frequency questionnaires. Analyses used Cox proportional hazards models to evaluate the association between fish and energy-adjusted omega-3 polyunsaturated fatty acid intake and the risk of major cardiovascular disease, defined as a composite outcome of myocardial infarction, stroke, and cardiovascular death, in 38,392 women in the final analytic sample (96%).
Results: During 713,559 person years of follow-up, 1,941 cases of incident major cardiovascular disease were confirmed. Tuna and dark fish intake was not associated with the risk of incident major cardiovascular disease (p-trend >0.05). Neither α-linolenic acid nor marine omega-3 fatty acid intake was associated with major cardiovascular disease or with individual cardiovascular outcomes (all p-trend >0.05). There was no effect modification by age, BMI, or baseline history of hypertension.
Conclusions: In this cohort of women without history of cardiovascular disease, intakes of tuna and dark fish, α-linolenic acid, and marine omega-3 fatty acids were not associated with risk of major cardiovascular disease.
Fish consumption benefits and PFAS risks: Epidemiology and public health recommendations.
Hamade A Toxicol Rep. 2024; 13:101736.
PMID: 39391711 PMC: 11465044. DOI: 10.1016/j.toxrep.2024.101736.
Yan Q, Liu Y, Barrett C, Haake K, Seeler D, May O Biotechnol Lett. 2024; 46(3):373-383.
PMID: 38493279 DOI: 10.1007/s10529-024-03472-5.
Current Evidence and Future Directions of Omega-3 Supplementation and Cardiovascular Disease Risk.
Dwiputra B, Santoso A, Purwowiyoto B, Radi B, Pandhita B, Fatrin S Int J Angiol. 2024; 33(1):1-7.
PMID: 38352637 PMC: 10861298. DOI: 10.1055/s-0043-1777258.
Ma Y, Zheng Z, Zhuang L, Wang H, Li A, Chen L Nutrients. 2024; 16(1).
PMID: 38201983 PMC: 10780780. DOI: 10.3390/nu16010152.
Ricci H, Gaeta M, Franchi C, Poli A, Battino M, Dolci A Nutrients. 2023; 15(21).
PMID: 37960192 PMC: 10647504. DOI: 10.3390/nu15214539.